IPSC
Century Therapeutics Inc
NASDAQ: IPSC · HEALTHCARE · BIOTECHNOLOGY
$2.20
+0.00% today
Updated 2026-04-29
Market cap
$396.78M
P/E ratio
—
P/S ratio
3.64x
EPS (TTM)
$-0.14
Dividend yield
—
52W range
$0 – $3
Volume
1.3M
Century Therapeutics Inc (IPSC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-8.78%
Operating margin
-13.80%
ROE
-5.98%
ROA
-3.26%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | $950.79M | — | 6.52% | — | — |
| 2016 | $470.32M | — | 0.53% | — | — |
| 2019 | $0.00 | $-244.77M | — | — | — |
| 2020 | $0.00 | $-53.58M | — | — | — |
| 2021 | $1.06M | $-95.82M | -433.08% | -8,968.15% | -9,057.09% |
| 2022 | $5.20M | $-130.93M | 100.00% | -2,574.17% | -2,518.41% |
| 2023 | $2.23M | $-136.67M | 100.00% | -6,556.87% | -6,115.12% |
| 2024 | $6.59M | $-126.57M | 100.00% | -2,096.48% | -1,920.87% |
| 2025 | $109.16M | $-9.58M | 88.00% | -13.78% | -8.78% |